Uncapped: Stories from the Grey Market

Just normal life in this crazy grey market communityIn this episode, I look at another ridiculous corner of the grey market community, where public kit photos can suddenly become a copyright issue, and a petty trademark attempt over the name K-Hole somehow becomes part of the drama. From the JEEP T30 fallout to a completely separate attempt to claim ownership over my server name, K -Hole, this one...

A practical guide to navigating vendors, risk, and uncertainty for those new to this world This guide is for anyone trying to crack the grey market for the first time. It’s what I would do if I were starting out now, knowing everything I know today. This episode covers the basics: what to do after joining my servers, how to start reading the market, and how to find a vendor for your very first ord...

This episode breaks down what GMP and cGMP actually mean, and why broad cGMP claims on RUO peptide websites should be treated with scepticism. GMP and cGMP are strict quality systems overseen by regulators such as the FDA. They require traceability, documented processes, controlled environments, QA oversight, and inspection. If those controls are missing, the GMP claim falls apart. A major grey-ma...

How “seized shipments” turn into second profits and why the same buyers may pay twice Scams are nothing new in the grey market. But this one works a little differently. In this episode, we break down what’s being described as the “Phoenix group buy scam” a pattern where a failed or allegedly failed group buy may not be the end of the story. Instead, it can become the starting point for something e...

This episode explores a side of the grey zone that isn’t talked about enough. Not the peptides. Not the vendors. Not the scams. But the people. Inside tight-knit communities, friendship often comes with conditions. You’re valuable while you’re useful. But when that changes, so does the relationship. From gossip, alt accounts, back stabbing and surveillance… to something more personal, the emotiona...

Scams, impersonators, vendor disputes, disappearing chats, and a collaboration offer I definitely wasn’t expecting. This episode is a real-time look at what one day in the grey zone actually looks like for me, narrated in my own voice.

What really happens when tirzepatide and vitamin B12 are mixed in the same vial? In this deep dive, we break down the science behind Eli Lilly’s recent warning and preprint, which identified a previously unknown tirzepatide–B12 molecular complex in compounded samples, in some cases making up a significant portion of the vial. The analysis also revealed major potency variation , with some products...

What their data shows and what it still doesn't explain. What happens when a blockbuster drug meets a common vitamin? In this deep dive, we unpack Eli Lilly’s warning about tirzepatide mixed with vitamin B12, and the science behind the controversy. A newly released preprint shows that when the two are combined, they can form a previously unknown molecular complex, detected in real world samples. S...

Why do some labs report 99%+ purity for NAD, while others refuse to give a purity number at all? This episode unpacks what is known as the NAD Testing Paradox. NAD is often analysed using methods designed for peptides, but chemically it behaves very differently. Because NAD naturally breaks down into related molecules like nicotinamide, ADP-ribose, AMP and ADP, purity numbers can sometimes reflect...

How Telehealth, US Manufacturing and 503A Ambitions are Rebuilding the Peptide Market The peptide market may be moving into a new phase. For years, much of the industry operated through Research Use Only (RUO) websites selling peptides in a legal grey zone. But that model is coming under pressure from payment processors, regulators, and changing mrket expectations. This episode explores what may b...

For years the grey-market peptide ecosystem operated in a strange legal balance. Products were sold under “Research Use Only” labels while being widely discussed in wellness communities, clinics, and online forums. Regulators knew the contradiction existed, but the system continued to function. So what is actually destabilising the RUO model now? In this episode we look at a factor that rarely get...

In this episode we unpack the shift from Research Use Only (RUO) peptides to the emerging Physician Use Only (PUO) label. At first glance, PUO might look like a move toward a more legitimate, physician-driven distribution model. But a closer look suggests something more complex. PUO is not an FDA regulatory category and does not automatically place peptides inside licensed pharmacy frameworks such...

In this audio version episode of K-Hole Origins: My Road to Grey, I talk about my experience with a vendor known as Cora and how a seemingly normal transaction slowly turned into a lesson in how the grey market actually works. It started in March 2024. Cora approached me warmly, calling me “dear friend,” reassuring me about shipping and reship policies, and sending an Alibaba payment link for tirz...

XCE goes dark, panic spreads, and the scramble to replace a dominant vendor begins. In this episode of K-Hole Origins, I share the surreal reality of early group buys, the post-XCE chaos, and the moment I realised the grey market was never just about peptides, it was about power, loyalty, and who fills the vacuum next. 

In Episode 2 of K-Hole Origins: My Road to Grey, my first peptide order from China finally arrives. What should have been a straightforward experiment quickly raises doubts and pulls me deeper into the strange dynamics of the grey-market peptide community

In this episode I share the personal story of how I entered the grey-market peptide world, from early experiences with GLP-1 medications to placing my first direct order from China, the beginning of the journey that eventually led to K-Hole.

This episode of Behind the Vial explores what happens just before peptides are freeze-dried. It looks at the stage where the peptide is still in liquid solution, covering sterile filtration, solution preparation, peristaltic pump setup, and manual vial filling under laminar airflow. Using real factory footage, the episode shows how the solution is filtered, transferred, and dispensed into vials be...

GLP1Forum; Manipulated Labels, Word Filters & Bans In grey-market communities, information and reputation are everything. But what if the reputations people see forming online aren’t as organic as they appear? This piece explores how moderation tools, word filters, bans, and platform design can influence which narratives survive and which disappear. Sometimes rumours spread. Sometimes they’re...

This episode explains the lyophilisation process used in peptide manufacturing, showing how liquid formulations are freeze dried to improve stability. It covers the key stages of freezing, primary drying, secondary drying, and final stoppering, and explains how water is removed by sublimation under vacuum. Using real factory footage from Aaron’s Biochemapi facility, the episode walks through what...

This is a summary of my interview with Alex , co-founder of Uzorak , a new peptide testing lab based in Zagreb, Croatia , planning to operate globally. Alex comes from a health-tech background, including a DNA analytics company , and says his own peptide research is what pushed him into building a testing lab. His core argument is simple: in an unregulated market, testing standards should be highe...

In this deep dive, we break down drop-shipping in grey peptide markets and why it’s not “just logistics.” In this world, logistics determines custody, accountability, and verification. A polished storefront that accepts PayPal or credit cards may actually be acting as a broker: taking fiat payments, converting to crypto, and routing orders to an upstream supplier the buyer never sees. We also unpa...

If you’ve ever opened a COA, seen “99% purity,” and felt instant relief… this one’s for you. Because that number is usually HPLC-UV purity , and UV purity isn’t a statement about the whole vial, or even a guarantee of molecular identity. It’s a statement about what the detector can see under a specific method, and how the lab calculates the percentage. In regulated pharma, that UV number sits insi...

Same Script, New Name Just when the Bella story looked finished, the pattern resurfaced, under a new name. In Episode 5, the script repeats. A new vendor appears. A polished pitch. A confident backstory. Claims of factory access, quality control, and “no pressure.” The language feels familiar. The structure feels familiar. And then the price list lands, almost identical in layout, formatting, and...

Undercover at Checkout This episode follows an undercover buyer taking Bella to the point that matters: payment. The pattern stays consistent: hook with cheap shipping + fast delivery, deflect COA questions, then pivot the conversation off Discord and into WhatsApp when risk questions appear. At checkout, the “payment ladder” shows up: push crypto first, fall back to PayPal Friends & Family, t...

Touchdowns and Testimonials, when the threads converged The morning after the Bella interview, Plotting Profits reappears with the same sales loop behaviour: a casual re entry (“hello”), a guilt nudge (“you didn’t get back to me”), then the hook (“prices went down recently”) followed by the familiar move: get the buyer off platform and keep the catalogue moving. That trail leads straight into Alis...